Esketamine Nasal Spray Reduces Anhedonia in Patients with Depression
Credit: Adobe Stock/ THANANIT A study showed that repeated administration of esketamine nasal spray effectively reduces anhedonia in…
Hypothalamic neurons help maintain blood sugar during daily activities
The brain controls the release of glucose in a wide range of stressful circumstances, including fasting and low…
Esketamine Plus Dexmedetomidine Boosts Sleep in Comorbid Insomnia, Depression
Credit: Adobe Stock/ Viacheslav Yakobchuk A study showed that patients with comorbid insomnia and depression treated with dexmedetomidine…
Dyslipidemia, Other Metabolic Syndrome Factors May Raise Parkinson’s Disease Risk
A larger waistline and higher blood pressure, among other factors connected to metabolic syndrome, may be connected to…
People With Gout at Risk for Chronic Opioid Use
Lindsay N. Helget MD University of Nebraska Medical Center A new study from the Veterans Health Administration (VA)…
Is a statin drug right for you? Researchers try to right-size the risk
It’s a math problem with life-and-death consequences. When a new and improved model for estimating the risk of…
Patients Prioritize Efficacy in Food Allergy Treatment Over Method, Frequency
Alexis T. Mickle, MSc Credit: LinkedIn In a discrete choice experiment, US patients tended to prefer more efficacious,…
Rocket Pharma’s shares soar after US FDA lets gene therapy trial resume
Rafael Henrique | SOPA Images | AP The U.S. health regulator has allowed a study of Rocket Pharmaceuticals’…
Cervical Cancer, Hodgkin Lymphoma Increase ASCVD Risk
New prospective cohort research has found that cervical cancer or Hodgkin lymphoma was associated with an increased risk…
Liver Stiffness and Fat Content May Lead to Coronary Heart Disease, Study Suggests
A recent retrospective study has demonstrated the nonlinear positive correlation between liver stiffness and fat content and coronary…
Systemic Inflammation Increases Healthcare Costs and Resource Utilization in ASCVD, CKD
New research is shedding light on stark increases in healthcare resource utilization and costs among individuals with atherosclerotic…
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines
Ozempic® is the GLP-1 with the most FDA-approved uses for patients with type 2 diabetes including, improvement of…